Fairmount Funds Management LLC 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:15 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Fairmount Funds Management LLC | 0 0.000% |
-6,632,015 (Position Closed) |
Filing |
| 2024-02-14 3:47 pm Purchase |
2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Fairmount Funds Management LLC | 6,632,015 9.900% |
1,362,728 (+25.86%) |
Filing |
| 2023-02-14 3:45 pm Purchase |
2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Fairmount Funds Management LLC | 5,269,287 9.900% |
3,219,287 (+157.04%) |
Filing |
| 2022-08-25 09:32 am Purchase |
2022-08-16 | 13G | Terns Pharmaceuticals, Inc. TERN |
Fairmount Funds Management LLC | 2,050,000 5.450% |
2,050,000 (New Position) |
Filing |